Pune, India, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The global Metformin Hydrochloride Tablets Market size is expected to gain momentum owing to the rising prevalence of diabetes during the forecast period ...

Pune, Nov. 11, 2022 (GLOBE NEWSWIRE) -- “Glоbаl Metformin Hydrochloride Маrkеt” іѕ thе tіtlе оf а rесеntlу рublіѕhеd rероrt bу JCMR market research. Тhе rеѕеаrсh ѕtudу іnvоlvеd ехреrt оріnіоn and with ...

One of the manufacturers of a Type 2 diabetes drug, Metformin Hydrochloride Extended-Release Tablets, extended its recall of its 500mg and 750 mg pills, the U.S. Food and Drug Administration reported ...

The Metformin Hydrochloride API Market report is a look of first-hand information, qualitative and quantitative assessment by market analysts, inputs from industry experts and industry participants ...

The European Commission has approved JENTADUETO for use alongside diet and exercise to improve glycemic control in adults with type 2 diabetes who are inadequately controlled on their maximally ...

New treatment combines DPP-4 inhibitor, linagliptin (the active ingredient in Tradjenta™ (linagliptin) tablets), and metformin in a single tablet, taken twice-daily, to lower blood sugar in adults ...

A recall has been ordered for a high-profile diabetes drug after producers discovered it contained alarmingly high levels of a cancer-causing impurity. Marksans Pharma Limited has recalled metformin ...

Zituvio and combination products include Zituvio™ (sitagliptin), Zituvimet™ (sitagliptin and metformin hydrochloride) and Zituvimet™ XR (sitagliptin and metformin hydrochloride) extended-release ...

Metformin is one of the most commonly used drugs in the treatment of diabetes type 2. It is a biguanide. This application note describes the assay of metformin hydrochloride in compliance with USP ...

Another series of diabetes medications have been recalled by Viona Pharmaceuticals over cancer concerns due to the ingredient N-nitrosodimethylamine (NDMA). NDMA is classified as a probable human ...

PRINCETON, N.J.--(BUSINESS WIRE)--Sun Pharmaceutical Industries, Inc. (SUN PHARMA), a wholly owned subsidiary of Sun Pharmaceutical Industries Ltd. is voluntarily recalling one lot of RIOMET ER™ ...